Pregled bibliografske jedinice broj: 1038460
Hyperprolactinemia-side effect or part of the illness
Hyperprolactinemia-side effect or part of the illness // Psychiatria Danubina, 31 (2019), Suppl2; 148-152 (domaća recenzija, članak, stručni)
CROSBI ID: 1038460 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Hyperprolactinemia-side effect or part of the
illness
Autori
Vuk Pisk, Sandra ; Matić, Katarina ; Gereš, Natko ; Ivezić, Ena ; Ruljančić, Nedjeljka ; Filipčić, Igor
Izvornik
Psychiatria Danubina (0353-5053) 31
(2019), Suppl2;
148-152
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
hyperprolactinemia ; prolactin ; antipsychotics ; psychotic disorders ; first psychotic episode
Sažetak
Background: Hyperprolactinemia is associated with side effect of antipsychotics in people suffering from psychotic disorders. However, increased prolactin levels were found in patients suffering from the first psychotic episode who were not receiving antipsychotic therapy. The assumption of this study is that the abnormality in the level of prolactin is associated with the effect and influence of the disease, not the therapy that is carried out. Subjects and methods: Study involved 54 female patients hospitalized in Psychiatric hospital "Sveti Ivan", whose average age was 33.9 years. All patients had been diagnosed with a psychotic disorder (according to MKB-10, F20- F29). 18 patients had their first psychotic episode, while 36 patients had relapses of psychotic disorder. The methods used were: PANSS scale and measurement of prolactin concentration (Immunoanalyzer ACCESS 2, CLIA method). Arithmetic mean, standard deviations, correlation coefficient, Mann Whitney U test and the chi-squared test were used. Results: 75.5% of patients had prolactin values above the reference values (min 121, max 4192 ml/L). In a sample of patients with first psychotic episode, 77.8% had elevated prolactin levels, while among re- hospitalized patients, elevated levels had 74.2%. Statistically significant results were obtained: patients with higher pronounced symptoms had higher prolactin values, especially particles on PANSS: P1 (delusions), N4 (Apathy), G15 (preoccupation) and G16 (active avoidance). Conclusion: Elevated prolactin in patients has been demonstrated regardless of antipsychotic therapy, therefore the question of etiology of hyperprolactinemia in psychotic disorders is questionable. The association of hyperprolactinemia with the severity of the clinical picture has also been demonstrated, higher prolactin values indicating a stronger clinical picture, which calls into question the protective role of prolactin in psychotic disorders.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Psihijatrijska bolnica "Sveti Ivan" Zagreb,
Fakultet za dentalnu medicinu i zdravstvo, Osijek
Profili:
Nedjeljka Ruljančić
(autor)
Natko Gereš
(autor)
Igor Filipčić
(autor)
Sandra Vuk Pisk
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE